Cut through the noise, find the signal: Intelligence for serious healthcare leaders
Analysis updated November 9, 2026
ACO PC Flex is CMS's most aggressive attempt yet to break primary care loose from fee-for-service mechanics within the Shared Savings Program framework. The architecture signals something important: rather than creating a standalone capitation model (as ACO REACH does for total cost of care), CMS has chosen to graft prospective primary care payment onto MSSP's existing scaffolding. That design choice is both the model's greatest strength and its most consequential operational risk.
The Prospective Primary Care (PPC) Payment replaces FFS billing for eligible primary care services with a county-rate PBPM that has three structural components: the Base PPC Payment Amount, the Enhanced PPC Payment Amount, and a Population Adjustment. Critically, the County Base Rate is anchored to county-level average primary care spending, not the ACO's historical spending. This is an intentional redistributive mechanism. For low-revenue ACOs operating in historically underinvested markets — many serving Medicaid-dual or rural populations — the county-averaging methodology can generate payment premiums above what FFS would have produced. The financial paper is explicit: the rate design is intended to "increase payment for providers that have entrenched patterns of inappropriately low spending."
The Enhanced PPC Payment Amount is the model's most strategically significant design element. These Enhancement add-ons are explicitly not put at risk — CMS will not recoup them. This is a departure from standard shared savings logic and functions as a de facto grant for primary care infrastructure investment. For participating ACOs, the Enhanced Amount represents locked revenue regardless of year-end reconciliation outcomes.
The one-time Advance Shared Savings Payment of $250,000 paid in Q1 2025 is structured as a recoverable advance, not a grant — it is deducted from shared savings earned each subsequent performance year until repaid. For ACOs that generate strong savings, this is essentially free float. For ACOs that underperform, it becomes a multi-year tail liability.
One underappreciated design risk: PPCP eligibility complexity. The model layers exclusion criteria on top of MSSP's existing assignment methodology. Step 2-assigned beneficiaries are categorically ineligible for PPC Payment. Beneficiaries whose primary provider is a specialist, is enrolled in Periodic Interim Payments, or is participating in certain other capitation-based initiatives (Kidney Care First, Primary Care AHEAD, Geo AHEAD) are also excluded. ACOs with mixed-specialty participant lists or overlapping model participation face material revenue leakage that may not be visible until post-reconciliation. The PY2025 fee reduction deferral option (allowing some providers to defer until 2026) added a further eligibility bifurcation, creating sub-populations within a single ACO where PPC Payment applies to some beneficiaries but not others.
Revenue structure: An ACO's gross PPC Payment revenue is a function of PPCP-eligible beneficiary months multiplied by the applicable county rate (adjusted for risk, seasonality, geographic factors, and population adjustments). CMS does not publish aggregate county rates in this document, but the Rate Book structure (National Conversion Factor × County Relative Cost Index, trended using the Primary Care Prospective Administrative Trend) provides the framework. The 2025 Preliminary Rate Book trended 2023 expenditures forward at 5.114% for A&D and 6.588% for ESRD beneficiaries to reach 2024 dollar equivalents — the 2025 Updated and 2026 Rate Books use 2024 actuals directly, eliminating trend uncertainty for current periods.
Fee reduction offset: PPC Payment replaces — not supplements — FFS revenue for eligible primary care services. The 8% Operational Payment Precision Withhold (held pending final reconciliation) creates a cash flow gap that ACOs must bridge operationally. For an ACO with, say, $2M in annualized PPC Payment flow, that represents approximately $160,000 held in reserve at any given time. Combine this with the $250,000 Advance Shared Savings Payment deduction from future shared savings and a new ACO could face $400,000+ in constrained or deferred cash in year one.
Break-even threshold: The model's fixed administrative cost floor (the $250,000 advance is the explicit acknowledgment) suggests CMS believes ACO formation costs run at or above this level. For a low-revenue ACO with, say, 500 PPCP-eligible beneficiaries, monthly PPC Payment revenue in a mid-cost county might run $60–$80 PBPM, yielding $360,000–$480,000 annually in PPC flow. Against genuine care management infrastructure costs (care coordinator FTEs at $65,000–$85,000 salary fully loaded, health IT, reporting), the margin is thin at under 1,000 attributed lives. Realistically, the model favors ACOs that can achieve 1,500+ PPCP-eligible beneficiary months to generate sufficient Enhanced Amount revenue and shared savings probability to justify the operational investment.
Worst-case scenario: An ACO that enrolls, builds care management infrastructure, and then sees significant beneficiary attrition due to PPCP eligibility exclusions (particularly under Preliminary Prospective Assignment with Retrospective Reconciliation, where beneficiaries who shift from Step 1/3 to Step 2 at any quarterly run become ineligible for the entire performance year with recoupment triggered) faces both revenue loss and administrative burden simultaneously. Recoupment of already-paid PPC amounts for retroactively ineligible beneficiaries is structurally baked into the model.
Clear winners: New, low-revenue ACOs in underserved markets. The county-averaging rate methodology specifically advantages providers who have historically been paid below county norms — a direct function of serving lower-income, dual-eligible, or Medicaid-heavy populations in FFS. If your FFS primary care revenue runs 15–20% below county average, the PPC Payment may represent a meaningful step-up payment before Enhanced Amounts are even applied.
FQHCs and RHCs: Structurally differentiated but operationally complex. These settings receive separate Add-On Amounts above the County Base Rate. However, their beneficiaries are excluded from the County Base Rate calculation itself, tracked separately by care focus, and subject to distinct fee reduction comparisons. FQHC-affiliated ACOs need to model their specific Add-On amounts against their current encounter rate payment to determine net financial direction.
Disadvantaged: Larger, established ACOs. CMS explicitly states it does not intend to open another application round. The 23 current participants represent a closed universe. Established ACOs with high historical primary care spending relative to county averages will see less benefit from rate averaging — they may already be at or above the county norm, meaning the PPC Payment functions largely as a FFS replacement with Enhanced Amounts as the only net new revenue.
MSSP interaction: PC Flex ACOs cannot simultaneously receive Advance Investment Payments (AIP) or Prepaid Shared Savings (PSS). For ACOs that qualified for AIP — a meaningful capital source for new and low-revenue ACOs under prior program rules — this is a genuine trade-off requiring explicit modeling. The $250,000 Advance Shared Savings Payment is the model's substitute, but AIP could exceed that amount for some organizations.
MA plan implications: MA beneficiaries are categorically excluded from PPCP eligibility. In highly penetrated MA markets, an ACO with 40–50% of its attributed population in MA plans will see its PPCP-eligible denominator compressed significantly. Market-level MA penetration rates should be a primary filter in evaluating PPC Payment revenue projections.
Physicians: The shift from visit-based to PBPM payment is operationally liberating and financially uncertain simultaneously. Primary care physicians gain the ability to fund non-billable care activities — proactive outreach, care navigation, behavioral health integration — that FFS structurally penalizes. However, the fee reduction mechanism (FFS claims for eligible primary care services are reduced to zero for PPCP-eligible beneficiaries, with PPC Payment as the offset) eliminates the visit-volume safety net. Physicians whose compensation models remain RVU-based will face internal misalignment unless the ACO restructures compensation to reflect PBPM revenue logic.
Health systems: Systems with employed primary care practices face a revenue reclassification challenge. PPC Payment flows to the ACO entity, not directly to practice TINs, requiring the system to develop internal allocation methodologies. The Enhanced Amount's non-recoupable status makes it attractive as a stable funding source for care management infrastructure — systems should model this explicitly as a capital planning input. However, systems must also manage the PPCP eligibility exclusion risk for beneficiaries whose primary provider is a specialist TIN within the system.
Hospitals: CAH Method II and HOPD-based primary care services are included in ACO PC Flex expenditure calculations and subject to fee reductions for PPCP-eligible beneficiaries. Hospital-based primary care practices participating in ACO PC Flex need to understand that their outpatient primary care billing will be subject to the same FFS replacement mechanics as office-based practices — a non-trivial revenue cycle and coding implication that should be addressed operationally before the fee reduction phase is fully implemented.
MA plans: The model excludes MA-enrolled beneficiaries from all PPC Payment mechanics, so direct financial exposure for MA plans is minimal. However, if ACO PC Flex successfully improves primary care quality and chronic disease management in FFS Medicare populations, the model creates a data asymmetry — ACO PC Flex participants will accumulate richer longitudinal care management experience with a defined population that MA plans in the same market cannot easily replicate or benchmark against.
With no additional application rounds anticipated, ACO PC Flex represents a closed experiment. The 23 current participants carry disproportionate strategic importance as proof points for whether prospective primary care payment within MSSP can generate savings — and whether CMMI under Abe Sutton's leadership will expand this payment architecture broadly or treat it as a terminated pilot.